Drug Database
M05BA06 ibandronic acid
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Bondronat 2 mg Concentrate for Solution for Infusion
- POM Bondronat 50 mg Film-coated Tablets
- POM Bondronat 6 mg Concentrate for Solution for Infusion
- POM Bonviva 150 mg Film-coated Tablets
- POM Bonviva 3 mg Solution for Injection
- POM Ibandronic acid 150 mg film-coated tablets
- POM Ibandronic acid 150 mg Film-coated Tablets
- POM Ibandronic Acid 150mg Film-Coated Tablets
- POM Ibandronic acid 1mg concentrate for solution for infusion
- POM Ibandronic acid 2mg concentrate for solution for infusion
- POM Ibandronic acid 50 mg film-coated tablets
- POM Ibandronic acid 50mg film coated tablets
- POM Ibandronic acid 6mg concentrate for solution for infusion
- POM Ibandronic acid Accord 2 mg concentrate for solution for infusion
- POM Ibandronic acid Accord 2mg/6 mg concentrate for solution for infusion
- POM Ibandronic acid Accord 3 mg solution for injection in pre-filled syringe
- POM Ibandronic acid Accord 6 mg concentrate for solution for infusion
- POM Ibandronic Acid Mylan 150 mg Film-coated Tablets
- POM Quodixor 150mg film-coated tablets
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).